Literature DB >> 7748750

Transplantation of melanocytes in vitiligo.

M J Olsson1, L Juhlin.   

Abstract

We report the results of a study on 100 patients (aged 12-68) with vitiligo, who were treated by transplantation of cultured autologous melanocytes to the depigmented areas, after removal of the epidermis at the recipient site by dermabrasion. The melanocytes were cultured from a 2 x 3 cm2 superficial shave biopsy taken from pigmented buttock skin. After 2-3 weeks in culture, 700-1000 cells per mm2 were applied on 60-500 cm2 dermabraded areas, and occluded for 1 week. The repigmented portion of the total treated area amounted to 95-100% in 40 patients, 65-94% in 32, 20-64% in 22, and 0-19% in six. It was more difficult to achieve complete pigmentation on the fingers, elbows and knees. In the first few months following the procedure, the treated areas were often hypo- or hyperpigmented, but after 6-8 months they had acquired the same colour as the surrounding skin. No scarring or other side-effects occurred. The donor site had repigmented after 3-6 months in all but two patients, who also showed poor pigmentation in the transplanted areas. At follow-up after 1 and 2 years in 50 and 10 patients, respectively, the repigmented areas remained unchanged. The method is time-consuming, but the results obtained indicate that the procedure can be valuable in motivated patients, when the extent of vitiligo does not exceed 30% of the total body area, and when the areas to be treated are not actively extending.

Entities:  

Mesh:

Year:  1995        PMID: 7748750     DOI: 10.1111/j.1365-2133.1995.tb08715.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Melanocyte stem cells as potential therapeutics in skin disorders.

Authors:  Ju Hee Lee; David E Fisher
Journal:  Expert Opin Biol Ther       Date:  2014-08-08       Impact factor: 4.388

3.  Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo.

Authors:  Pedro Redondo; Ana Giménez de Azcarate; Laura Marqués; María García-Guzman; Enrique Andreu; Felipe Prósper
Journal:  Dermatol Res Pract       Date:  2011-08-18

4.  Two cases of focal scrotal vitiligo successfully treated by autologous cultured melanocyte transplantation.

Authors:  Xiaowen Li; Weisong Hong; Ai-E Xu
Journal:  Dermatol Ther (Heidelb)       Date:  2014-03-27

5.  A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.

Authors:  Dimin Zhang; Xiaodong Wei; Weisong Hong; Lifang Fu; Guopei Qian; Ai-E Xu
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

6.  A Prospective Observational Comparative Study of Novel Autologous Negative Pressure Epidermal Harvesting System (ANPEHS or EHS) and Suction Blister Grafting (SBG) in Treatment of Stable Vitiligo.

Authors:  Sukriti Baweja; Satish Chand
Journal:  J Cutan Aesthet Surg       Date:  2020 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.